Literature DB >> 29729072

Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus.

Beatriz Moreno1, Ana Paula de Faria1, Alessandra Mileni Versuti Ritter1, Lara Buonalumi Tacito Yugar2, Silvia Elaine Ferreira-Melo1, Rivadavio Amorim3, Rodrigo Modolo4, André Fattori4, Juan Carlos Yugar-Toledo2, Antonio Coca5, Heitor Moreno1,4.   

Abstract

This study aimed to evaluate the effects of glycated hemoglobin (HbA1c ) on flow-mediated dilation, intima-media thickness, pulse wave velocity, and left ventricular mass index in patients with resistant hypertension (RHTN) comparing RHTN-controlled diabetes mellitus and RHTN-uncontrolled type 2 diabetes mellitus. Two groups were formed: HbA1c <7.0% (RHTN-controlled diabetes mellitus: n = 98) and HbA1c ≥7.0% (RHTN-uncontrolled diabetes mellitus: n = 122). Intima-media thickness and flow-mediated dilation were measured by high-resolution ultrasound, left ventricular mass index by echocardiography, and arterial stiffness by carotid-femoral pulse wave velocity. No differences in blood pressure levels were found between the groups but body mass index was higher in patients with RHTN-uncontrolled diabetes mellitus. Endothelial dysfunction and arterial stiffness were worse in patients with RHTN-uncontrolled diabetes mellitus. Intima-media thickness and left ventricular mass index measurements were similar between the groups. After adjustments, multiple linear regression analyses showed that HbA1c was an independent predictor of flow-mediated dilation and pulse wave velocity in all patients with RHTN. In conclusion, HbA1c may predict the grade of arterial stiffness and endothelial dysfunction in patients with RHTN, and superimposed uncontrolled diabetes mellitus implicates further impairment of vascular function. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiovascular remodeling; diabetes mellitus; flow-mediated dilation; pulse wave velocity; resistant hypertension

Mesh:

Substances:

Year:  2018        PMID: 29729072      PMCID: PMC8030801          DOI: 10.1111/jch.13293

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  57 in total

Review 1.  34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?

Authors:  Rita F Redberg; Robert A Vogel; Michael H Criqui; David M Herrington; Joao A C Lima; Mary J Roman
Journal:  J Am Coll Cardiol       Date:  2003-06-04       Impact factor: 24.094

Review 2.  Obesity and insulin resistance in resistant hypertension: implications for the kidney.

Authors:  Akhilesh Rao; Vishwam Pandya; Adam Whaley-Connell
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 3.  2. Classification and Diagnosis of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

Review 4.  6. Glycemic Targets.

Authors: 
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

5.  Cardiovascular Risk Factor Control for All.

Authors:  Philip Greenland; Valentin Fuster
Journal:  JAMA       Date:  2017-07-11       Impact factor: 56.272

6.  Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction.

Authors:  Juan Carlos Yugar-Toledo; Jose Eduardo Tanus-Santos; Maricene Sabha; Márcio Gonçalves Sousa; Máira Cittadino; Lúcia Helena Buonalumi Tácito; Heitor Moreno
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

7.  Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus.

Authors:  Beatriz Moreno; Ana Paula de Faria; Alessandra Mileni Versuti Ritter; Lara Buonalumi Tacito Yugar; Silvia Elaine Ferreira-Melo; Rivadavio Amorim; Rodrigo Modolo; André Fattori; Juan Carlos Yugar-Toledo; Antonio Coca; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-05       Impact factor: 3.738

8.  Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.

Authors:  Vaia Lambadiari; George Pavlidis; Foteini Kousathana; Maria Varoudi; Dimitrios Vlastos; Eirini Maratou; Dimitrios Georgiou; Ioanna Andreadou; John Parissis; Helen Triantafyllidi; John Lekakis; Efstathios Iliodromitis; George Dimitriadis; Ignatios Ikonomidis
Journal:  Cardiovasc Diabetol       Date:  2018-01-08       Impact factor: 9.951

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 10.  Vascular stiffness in insulin resistance and obesity.

Authors:  Guanghong Jia; Annayya R Aroor; Vincent G DeMarco; Luis A Martinez-Lemus; Gerald A Meininger; James R Sowers
Journal:  Front Physiol       Date:  2015-08-14       Impact factor: 4.566

View more
  10 in total

Review 1.  Hypertension and Type 2 Diabetes-The Novel Treatment Possibilities.

Authors:  Agnieszka Przezak; Weronika Bielka; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

2.  Glycated Hemoglobin and Risk of Arterial Stiffness in a Chinese Han Population: A Longitudinal Study.

Authors:  Ze Han; Xiaoping Kang; Jie Zhang; Jinqi Wang; Yue Liu; Jia Liu; Zhiyuan Wu; Xia Li; Xiaoyu Zhao; Xiuhua Guo; Shuo Chen; Lixin Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

3.  Hypertension, Arterial Stiffness, and Diabetes: a Prospective Cohort Study.

Authors:  Xue Tian; Yingting Zuo; Shuohua Chen; Yijun Zhang; Xiaoli Zhang; Qin Xu; Shouling Wu; Anxin Wang
Journal:  Hypertension       Date:  2022-05-16       Impact factor: 9.897

4.  Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus.

Authors:  Beatriz Moreno; Ana Paula de Faria; Alessandra Mileni Versuti Ritter; Lara Buonalumi Tacito Yugar; Silvia Elaine Ferreira-Melo; Rivadavio Amorim; Rodrigo Modolo; André Fattori; Juan Carlos Yugar-Toledo; Antonio Coca; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-05       Impact factor: 3.738

5.  The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes.

Authors:  Teonchit Nuamchit; Duangduan Siriwittayawan; Piyanuch Thitiwuthikiat
Journal:  Vasc Health Risk Manag       Date:  2020-08-25

6.  The association between glycosylated haemoglobin and newly diagnosed hypertension in a non-diabetic Sudanese population: a cross-sectional study.

Authors:  Saeed M Omar; Imad R Musa; Omer Abdelbagi; Manal E Sharif; Ishag Adam
Journal:  BMC Cardiovasc Disord       Date:  2022-05-10       Impact factor: 2.174

7.  A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults.

Authors:  Yang Wu; Haofei Hu; Jinlin Cai; Runtian Chen; Xin Zuo; Heng Cheng; Dewen Yan
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

8.  Arterial Stiffness and HbA1c: Association Mediated by Insulin Resistance in Hispanic Adults.

Authors:  Alexandro J Martagón; Carlos A Fermín-Martínez; Neftali Eduardo Antonio-Villa; Roopa Mehta; Paloma Almeda-Valdés; Arsenio Vargas-Vázquez; Liliana Muñoz-Hernández; Donají V Gómez-Velasco; Daniel Elías-López; Gabriela A Galán-Ramírez; Fabiola Mabel Del Razo-Olvera; Ivette Cruz-Bautista; Rogelio González-Arellanes; Carlos A Aguilar-Salinas
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

9.  Heparanase upregulation from adipocyte associates with inflammation and endothelial injury in diabetic condition.

Authors:  Nur Arfian; Wiwit Ananda Wahyu Setyaningsih; Muhammad Mansyur Romi; Dwi Cahyani Ratna Sari
Journal:  BMC Proc       Date:  2019-12-16

Review 10.  Mechanisms of Endothelial Dysfunction in Pre-eclampsia and Gestational Diabetes Mellitus: Windows Into Future Cardiometabolic Health?

Authors:  Colm J McElwain; Eszter Tuboly; Fergus P McCarthy; Cathal M McCarthy
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-11       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.